Tertiary amine pyrazolones and their salts as inhibitors of mutant superoxide dismutase 1-dependent protein aggregation for the treatment of amyotrophic lateral sclerosis

Documenti analoghi

• ADME-Guided Design and Synthesis of Aryloxanyl Pyrazolone Derivatives to Block Mutant Superoxide Dismutase 1 (SOD1) Cytotoxicity and Protein Aggregation: Potential Application for the Treatment of Amyotrophic Lateral Sclerosis
  di: Chen, Tian, et al.
  Pubblicazione: (2011)
• Arylazanylpyrazolone derivatives as inhibitors of mutant superoxide dismutase 1-dependent protein aggregation for the treatment of amyotrophic lateral sclerosis
  di: Zhang, Yinan, et al.
  Pubblicazione: (2013)
• Substituted pyrazolones require N(2) hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1
  di: Trippier, Paul C., et al.
  Pubblicazione: (2012)
• Arylsulfanyl Pyrazolones Block Mutant SOD1-G93A Aggregation. Potential Application for the Treatment of Amyotrophic Lateral Sclerosis
  di: Chen, Tian, et al.
  Pubblicazione: (2010)
• Proteasome Activation is a Mechanism for Pyrazolone Small Molecules Displaying Therapeutic Potential in Amyotrophic Lateral Sclerosis
  di: Trippier, Paul C., et al.
  Pubblicazione: (2014)